Rick Yang is Director & 10% at NeueHealth, Inc. (NEUE). They have made 7 open-market trades across 6 companies since 2021, most recently 2026-03-10.
CIK 0001851328
6 open-market purchases totalling $47.3M since 2021, against 1 sale. Across 6 scored buys the stock is down 11.3% at ninety days, and 16.4 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 50% | 33% |
| Avg Move | -5.5% | -1.8% | -11.3% |
| Alpha | -6.1% | -2.3% | -16.4% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KRRO | BUY | 2026-03-10 | 2026-03-12 | $11.11 | $2.3M | -23.3% | -0.7% | -23.0% |
| SGP | BUY | 2026-02-09 | 2026-02-11 | $16.00 | $15.0M | +4.8% | -5.0% | -13.7% |
| NEUE | SELL | 2025-10-02 | 2025-10-06 | $6.75 | $25K | N/A | N/A | N/A |
| MBX | BUY | 2024-09-16 | 2024-09-17 | $16.00 | $8.0M | +11.4% | +7.7% | -11.0% |
| KRRO | BUY | 2024-04-22 | 2024-04-24 | $56.00 | $1000K | -11.2% | -23.2% | -25.6% |
| SVRA | BUY | 2023-07-17 | 2023-07-19 | $3.00 | $1000K | +4.1% | +2.9% | +1.5% |
| GLUE | BUY | 2021-06-28 | 2021-06-30 | $19.00 | $19.9M | -18.5% | +7.5% | +4.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total | $306.7M |
Shares reported on the most recent Form 4, priced at the 2026-03-12 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.